DK1392292T3 - Pyranoindazoler og deres anvendelse til behandling af glaukom - Google Patents
Pyranoindazoler og deres anvendelse til behandling af glaukomInfo
- Publication number
- DK1392292T3 DK1392292T3 DK02734575T DK02734575T DK1392292T3 DK 1392292 T3 DK1392292 T3 DK 1392292T3 DK 02734575 T DK02734575 T DK 02734575T DK 02734575 T DK02734575 T DK 02734575T DK 1392292 T3 DK1392292 T3 DK 1392292T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyranoindazoles
- glaucoma
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29542901P | 2001-06-01 | 2001-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1392292T3 true DK1392292T3 (da) | 2006-05-29 |
Family
ID=23137684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02734575T DK1392292T3 (da) | 2001-06-01 | 2002-05-30 | Pyranoindazoler og deres anvendelse til behandling af glaukom |
Country Status (20)
Country | Link |
---|---|
US (2) | US6696476B2 (da) |
EP (1) | EP1392292B1 (da) |
JP (1) | JP2004535418A (da) |
KR (1) | KR100626255B1 (da) |
CN (1) | CN100384417C (da) |
AR (1) | AR036044A1 (da) |
AT (1) | ATE318821T1 (da) |
AU (1) | AU2002305732B2 (da) |
BR (1) | BR0210241A (da) |
CA (1) | CA2447480A1 (da) |
DE (1) | DE60209486T2 (da) |
DK (1) | DK1392292T3 (da) |
ES (1) | ES2258631T3 (da) |
HK (1) | HK1061212A1 (da) |
MX (1) | MXPA03010807A (da) |
PL (1) | PL366636A1 (da) |
PT (1) | PT1392292E (da) |
RU (1) | RU2273641C2 (da) |
WO (1) | WO2002098350A2 (da) |
ZA (1) | ZA200309034B (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960579B1 (en) | 1998-05-19 | 2005-11-01 | Alcon Manufacturing, Ltd. | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders |
US7005443B1 (en) * | 2000-03-17 | 2006-02-28 | Alcon, Inc. | 5-Hydroxy indazole derivatives for treating glaucoma |
AU784462B2 (en) * | 2000-03-31 | 2006-04-06 | Purdue Research Foundation | Phosphoramidate prodrugs |
ATE318821T1 (de) * | 2001-06-01 | 2006-03-15 | Alcon Inc | Pyranoindazole und ihre verwendung in der glaukombehandlung |
TW593302B (en) | 2001-12-20 | 2004-06-21 | Alcon Inc | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
WO2003057213A2 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
CA2495192A1 (en) * | 2002-08-30 | 2004-03-11 | Alcon, Inc. | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
JP2006511556A (ja) | 2002-12-13 | 2006-04-06 | アルコン,インコーポレイテッド | 新規のベンゾピラン類似体及び緑内障の治療のためのそれらの使用 |
WO2005025568A1 (en) * | 2003-09-04 | 2005-03-24 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
US7476687B2 (en) | 2003-11-26 | 2009-01-13 | Alcon, Inc. | Substituted furo[2,3-g]indazoles for the treatment of glaucoma |
US7129257B1 (en) | 2003-12-15 | 2006-10-31 | Alcon, Inc. | Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma |
US7338972B1 (en) | 2003-12-15 | 2008-03-04 | Alcon, Inc. | Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
TW200520760A (en) | 2003-12-15 | 2005-07-01 | Alcon Inc | Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma |
JP5173190B2 (ja) | 2004-08-25 | 2013-03-27 | 武田薬品工業株式会社 | 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法 |
US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
US7425572B2 (en) | 2004-12-08 | 2008-09-16 | Alcon, Inc. | Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
TW200744567A (en) * | 2005-09-23 | 2007-12-16 | Alcon Inc | Phenylethylamine analogs and their use for treating glaucoma |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
US20070293475A1 (en) * | 2006-06-20 | 2007-12-20 | Alcon Manufacturing Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
US20090247552A1 (en) * | 2006-07-31 | 2009-10-01 | Shirou Sawa | Aqueous liquid preparation containing amide compound |
WO2008016993A1 (en) * | 2006-08-01 | 2008-02-07 | Alcon Research, Ltd. | Intermediates and methods for serotonergic agonist synthesis |
US20080033183A1 (en) * | 2006-08-01 | 2008-02-07 | Alcon Manufacturing, Ltd. | Process for preparing pyranoindazole serotonergic receptor agonists |
US20080058533A1 (en) * | 2006-08-31 | 2008-03-06 | Alcon, Inc. | Pyranoindazole cyclic carbonates and methods of use |
WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
EP2510949A4 (en) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | THERAPEUTICS FOR FIBROMYALGIA |
WO2016139960A1 (ja) * | 2015-03-05 | 2016-09-09 | 株式会社ブリヂストン | ゴム組成物、ジエン系重合体の製造方法及びタイヤ |
TW201815766A (zh) * | 2016-09-22 | 2018-05-01 | 美商普雷辛肯公司 | 用於ido及tdo調節之化合物及方法以及其適應症 |
WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
CA3094336A1 (en) | 2018-03-20 | 2019-09-26 | Plexxikon Inc. | Compounds and methods for ido and tdo modulation, and indications therefor |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534580A1 (fr) | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
US5151444B1 (en) | 1987-09-18 | 1999-07-06 | R Tech Ueno Ltd | Ocular hypotensive agents |
US5296504A (en) | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
EP1224934A3 (en) | 1988-09-06 | 2003-03-26 | Pharmacia AB | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5578612A (en) | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
WO1992020338A1 (en) | 1991-05-10 | 1992-11-26 | Merrell Dow Pharmaceuticals Inc. | Method for the treatment of glaucoma |
JPH06508354A (ja) | 1991-06-21 | 1994-09-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | トリプタミン類似体、その合成法およびその5−ht↓1様または5−ht↓2受容体作用物質としての使用 |
US5352708A (en) | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5922773A (en) | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
US5510383A (en) | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
TW334423B (en) | 1993-10-22 | 1998-06-21 | Hoffmann La Roche | Tricyclic 1-aminoethylpyrrole-derivatives |
TW270114B (da) | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
US5874477A (en) | 1994-08-12 | 1999-02-23 | The University Of Hawaii | Method of treatment for malaria utilizing serotonin receptor ligands |
TW403738B (en) | 1994-08-12 | 2000-09-01 | Hoffmann La Roche | Tricyclic pyrazole derivatives |
US5998467A (en) | 1995-10-25 | 1999-12-07 | Mitsubishi Chemical Corporation | Medicine for oculopathy |
WO1997033579A1 (en) | 1996-03-13 | 1997-09-18 | Glaxo Group Limited | Medicaments comprising 5ht1-like receptor agonists with an increased absorption |
US5902815A (en) | 1996-09-03 | 1999-05-11 | Washington University | Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction |
WO1998018458A1 (en) | 1996-10-31 | 1998-05-07 | Alcon Laboratories, Inc. | Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma |
JP3560986B2 (ja) | 1997-01-13 | 2004-09-02 | 山之内製薬株式会社 | 5―ht2c受容体作用薬及びアミノアルキルインダゾール誘導体 |
GB9700899D0 (en) | 1997-01-17 | 1997-03-05 | Smithkline Beecham Plc | Novel treatment |
AU727654B2 (en) * | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
GB9819033D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds VI |
GB9819035D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Res Ltd | Chemical compounds VII |
US6664286B1 (en) | 1998-09-18 | 2003-12-16 | Alcon Manufacturing, Ltd. | Serotonergic 5ht2 agonists for treating glaucoma |
NZ512765A (en) | 1998-12-17 | 2003-10-31 | Wyeth Corp | 2,3,4,4A-tetrahydro-1H-pyrazino(1,2-A)quinoxalin- 5(6H)one derivatives being 5HT2C agonists |
GB9902047D0 (en) | 1999-01-29 | 1999-03-17 | Cerebrus Ltd | Chemical compounds XI |
US6713471B1 (en) | 1999-06-15 | 2004-03-30 | Bristol-Myers Squibb Pharma Company | Substituted heterocycle fused gamma-carbolines |
NZ516031A (en) | 1999-06-15 | 2003-10-31 | Bristol Myers Squibb Pharma Co | Substituted heterocycle fused gamma-carbolines |
PL365422A1 (en) | 2000-03-17 | 2005-01-10 | Alcon, Inc. | 5-hydroxy indazole derivatives for treating glaucoma |
AU5256301A (en) * | 2000-04-28 | 2001-11-12 | Yamanouchi Pharmaceutical Co., Ltd. | Froindazole derivative |
ATE318821T1 (de) * | 2001-06-01 | 2006-03-15 | Alcon Inc | Pyranoindazole und ihre verwendung in der glaukombehandlung |
-
2002
- 2002-05-30 AT AT02734575T patent/ATE318821T1/de not_active IP Right Cessation
- 2002-05-30 AU AU2002305732A patent/AU2002305732B2/en not_active Ceased
- 2002-05-30 BR BR0210241-2A patent/BR0210241A/pt not_active IP Right Cessation
- 2002-05-30 PT PT02734575T patent/PT1392292E/pt unknown
- 2002-05-30 MX MXPA03010807A patent/MXPA03010807A/es active IP Right Grant
- 2002-05-30 PL PL02366636A patent/PL366636A1/xx unknown
- 2002-05-30 RU RU2003137825/04A patent/RU2273641C2/ru not_active IP Right Cessation
- 2002-05-30 JP JP2003501392A patent/JP2004535418A/ja active Pending
- 2002-05-30 WO PCT/US2002/016861 patent/WO2002098350A2/en active IP Right Grant
- 2002-05-30 CA CA002447480A patent/CA2447480A1/en not_active Abandoned
- 2002-05-30 CN CNB02814774XA patent/CN100384417C/zh not_active Expired - Fee Related
- 2002-05-30 ES ES02734575T patent/ES2258631T3/es not_active Expired - Lifetime
- 2002-05-30 EP EP02734575A patent/EP1392292B1/en not_active Expired - Lifetime
- 2002-05-30 DK DK02734575T patent/DK1392292T3/da active
- 2002-05-30 KR KR1020037015621A patent/KR100626255B1/ko not_active IP Right Cessation
- 2002-05-30 DE DE60209486T patent/DE60209486T2/de not_active Expired - Fee Related
- 2002-05-31 AR ARP020102050A patent/AR036044A1/es unknown
- 2002-12-11 US US10/316,600 patent/US6696476B2/en not_active Expired - Lifetime
-
2003
- 2003-11-20 ZA ZA200309034A patent/ZA200309034B/en unknown
- 2003-11-24 US US10/722,042 patent/US6881749B2/en not_active Expired - Lifetime
-
2004
- 2004-06-16 HK HK04104368A patent/HK1061212A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2003137825A (ru) | 2005-04-20 |
EP1392292A4 (en) | 2004-08-11 |
AU2002305732B2 (en) | 2007-02-01 |
EP1392292A2 (en) | 2004-03-03 |
US6881749B2 (en) | 2005-04-19 |
PL366636A1 (en) | 2005-02-07 |
EP1392292B1 (en) | 2006-03-01 |
CN100384417C (zh) | 2008-04-30 |
HK1061212A1 (en) | 2004-09-10 |
ES2258631T3 (es) | 2006-09-01 |
US6696476B2 (en) | 2004-02-24 |
ATE318821T1 (de) | 2006-03-15 |
DE60209486D1 (de) | 2006-04-27 |
KR100626255B1 (ko) | 2006-09-21 |
ZA200309034B (en) | 2004-07-16 |
JP2004535418A (ja) | 2004-11-25 |
BR0210241A (pt) | 2004-08-10 |
AR036044A1 (es) | 2004-08-04 |
US20030171418A1 (en) | 2003-09-11 |
WO2002098350A3 (en) | 2003-02-27 |
PT1392292E (pt) | 2006-05-31 |
CA2447480A1 (en) | 2002-12-12 |
RU2273641C2 (ru) | 2006-04-10 |
KR20040010669A (ko) | 2004-01-31 |
WO2002098350A2 (en) | 2002-12-12 |
DE60209486T2 (de) | 2006-08-03 |
US20040106609A1 (en) | 2004-06-03 |
CN1592619A (zh) | 2005-03-09 |
MXPA03010807A (es) | 2004-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1392292T3 (da) | Pyranoindazoler og deres anvendelse til behandling af glaukom | |
NO20034169D0 (no) | MCH-antagonister og deres anvendelse ved behandling av fedme | |
DK1455785T3 (da) | Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse | |
DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
DK1083889T3 (da) | Tetrahydronaphthalenforbindelser og deres anvendelse til behandling af neurodegenerative sygdomme | |
DK1498413T3 (da) | 4-aminopicolinater og deres anvendelse som herbicider | |
DK1404809T3 (da) | Forbedrede hudsubstitutter og anvendelser deraf | |
DK1395567T3 (da) | 4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser | |
EE05507B1 (et) | Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks | |
NO20025357L (no) | Antranylamider og deres anvendelse som legemidler | |
NO20043370L (no) | N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer | |
DK1537096T3 (da) | Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf | |
NO20052699D0 (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
NO20033854L (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
DK1432417T3 (da) | Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer | |
IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
NO20033123D0 (no) | Terapeutisk hinnedannende sammensetning og behandlingsplan derav | |
DK1381382T3 (da) | Fremgangsmåder og præparater til behandling af öjensygdomme | |
DK1472221T3 (da) | Substituerede indoler, fremgangsmåde til fremstilling deraf og deres anvendelse til bekæmpelse af smerter | |
NO20020031D0 (no) | Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi | |
DK1461042T3 (da) | Anvendelse af desoxypeganin til behandling af klinisk depression | |
NO20043029L (no) | Karboksamidinderivater og deres anvendelse ved behandling av vaskulaere sykdommer | |
NO20030547L (no) | Azabicykliske derivater og deres terapeutiske anvendelse | |
NO20034172D0 (no) | Bisykliske guanidinderivater og terapeutiske anvendelser derav |